Medicare Enrolled

Dr. Steven Feiner, DO

Gastroenterology · Orlando, FL
Low-engagement
3885 OAKWATER CIR, Orlando, FL 32806
4078515600
In practice since 2006 (19 years)
NPI: 1407895758 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Feiner from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Feiner? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Feiner

Dr. Steven Feiner is a gastroenterology in Orlando, FL, with 19 years in practice.

Between the years covered by Open Payments, Dr. Feiner received a total of $3,520 from 37 pharmaceutical and/or device companies across 209 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Feiner is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice$ $3,520 industry payments

Industry Payment Transparency

Open Payments through 2022 ↗
$3,520
Total received (2018-2022)
Avg $704/year across 5 years
Top 45% in FL for gastroenterology
37
Companies
209
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,431 (97.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$89 (2.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2022
$211
2021
$794
2020
$354
2019
$872
2018
$1,289

Payments by company (2022)

Consulting
Speaking
Meals & Travel
Research
Takeda Pharmaceuticals U.S.A., Inc.
$682
AbbVie, Inc.
$481
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$434
Janssen Biotech, Inc.
$267
AbbVie Inc.
$208
GI Supply, Inc.
$169
PENTAX of America, Inc.
$148
OPKO Pharmaceuticals, LLC
$104
Intercept Pharmaceuticals, Inc.
$83
Amgen Inc.
$82
Nestle HealthCare Nutrition Inc.
$68
Daiichi Sankyo Inc.
$64
Axonics, Inc.
$63
PFIZER INC.
$62
Celgene Corporation
$51
UCB, Inc.
$48
VIVUS LLC
$46
Novo Nordisk Inc
$44
Medtronic, Inc.
$41
Braintree Laboratories, Inc.
$38
Shionogi Inc
$33
Gilead Sciences, Inc.
$27
VIVUS, Inc.
$26
Amarin Pharma Inc.
$26
Allergan Inc.
$23
Bausch Health US, LLC
$23
Endo Pharmaceuticals Inc.
$21
ABBVIE INC.
$19
Mallinckrodt LLC
$19
RedHill Biopharma Inc.
$18
Fresenius USA Marketing, Inc.
$18
INTERCEPT PHARMACEUTICALS, INC.
$17
Romark Laboratories, LC
$16
Alexion Pharmaceuticals, Inc.
$14
Shire North American Group Inc
$13
Lilly USA, LLC
$13
SANOFI PASTEUR INC.
$12
Top 3 companies account for 45.4% of total payments
Associated products mentioned in payments ›
ACTHAR · APRISO · Aimovig · Alinia Tablets 500mg 30 count bottle · Amitiza · Axonics r-SNM System · CREON · CapsoCam · Cimzia · Creon · Dexilant · EMGALITY · ENTYVIO · EVENITY · Entyvio · FLUZONE HIGH-DOSE · GATTEX · GI Genius · Humira · INFLECTRA · INJECTAFER · LINZESS · MAVYRET · MIGRANAL · MOTEGRITY · MOTOFEN · MOVIPREP · Mavyret · Mulpleta · NASCOBAL · OCALIVA · PANCREAZE · PLENVU · Pancreaze · Prolia · RELISTOR · Rayaldee · SOLIRIS · STELARA · SUPREP · Symproic · TRULANCE · Talicia · Trintellix · VIBERZI · Vascepa · Victoza · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a gastroenterology in Orlando?
Compare gastroenterologys in the Orlando area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologys nearby

Geographic Context

Gastroenterologys within 10 mi
115
Per 100K population
8.0
County median income
$77,011
Nearest hospital
ORLANDO HEALTH
0.0 mi

Data Sources

Provider Registry✓ NPPESWeekly updates
Medicare Enrollment✓ PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments✓ Open PaymentsCY 2022
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Feiner is a gastroenterology, and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Feiner receive payments from pharmaceutical companies?
Yes. Dr. Feiner received a total of $3,520 from 37 companies across 209 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Feiner) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologys in Orlando
Browse gastroenterologys in Orlando ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologys in FL
Gastroenterologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologys in FL
Which FL gastroenterologys receive the most from drug and device companies.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc..
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc..
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →